Micar Innovation (Micar21) is the winner of а prestigious award for Innovative enterprise of the year 2018
The National Competition “Innovative Enterprise of the Year” annually awards Bulgarian enterprises with successfully implemented innovative products, processes, services and practices on the Bulgarian and world markets.
Тhe 14th edition of the competition “Innovative Enterprise of the Year – 2018” took place during the National Innovation Forum on 6 December 2018.
The Forum with the participation of the President of the Republic of Bulgaria Mr. Rumen Radev features the award ceremony of the Innovative Enterprise of the Year 2018 national contest.
For Innovative Startup Enterprise, Micar Innovation (Micar21) was awarded an honorary certificate.
About Micar Innovation (Micar21)
Micar Innovation is a "factory" for discovering new drug molecules. The company has found a niche to create big public impact by improving the quality of people's lives through new blockbuster drug molecules for a large range of medical issues. Micar Innovation is focused on non-clinical Proof-of-Concepts (PoCs) in preclinical R&D field and Hit-to-Lead (H2L) achievements in fields such as neurology, oncology, the cardio-vascular system, dermatology, rare diseases, etc. Micar21 is the main platform for new small molecule drug candidates. The business model is based on patenting the newly discovered molecules, where licenses are then licensed to commercial partners (big pharma companies). The other model is setting up new spin-out companies to further develop the new drug molecule until the clinical PoC and the follow-up sale/licensing of the patent.Link to: Micar Innovation (Micar21)